Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (665) 665
Publication (100) 100
Paper (71) 71
Book Review (37) 37
Conference Proceeding (32) 32
Book / eBook (17) 17
Patent (15) 15
Book Chapter (8) 8
Newspaper Article (3) 3
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (303) 303
humans (258) 258
female (169) 169
male (149) 149
middle aged (126) 126
adult (111) 111
aged (90) 90
gastroenterology & hepatology (78) 78
experiment (77) 77
oncology (77) 77
particle physics (73) 73
physics - high energy physics - experiment (73) 73
animals (69) 69
cancer (66) 66
physics (60) 60
analysis (57) 57
high energy physics - experiment (56) 56
hep (55) 55
immunohistochemistry (49) 49
particle physics - experiment (47) 47
expression (46) 46
aged, 80 and over (44) 44
mice (42) 42
hep-ex (41) 41
high energy physics (41) 41
internet (40) 40
experimental results (36) 36
gastric cancer (35) 35
research (34) 34
cern lhc coll (33) 33
carcinoma (32) 32
diagnosis (32) 32
lhc-b (31) 31
p p: colliding beams (31) 31
prognosis (31) 31
p p: scattering (30) 30
stomach neoplasms - genetics (30) 30
treatment outcome (30) 30
clinical trials (29) 29
psychiatry (29) 29
cell biology (28) 28
ex (28) 28
gene expression (28) 28
proteins (28) 28
stomach neoplasms - pathology (28) 28
endocrinology & metabolism (27) 27
microbiology (27) 27
depression (26) 26
studies (26) 26
colorectal cancer (25) 25
care and treatment (24) 24
7000 gev-cms8000 gev-cms (23) 23
abridged index medicus (23) 23
cognitive-behavioral therapy (23) 23
intervention (23) 23
prevention (23) 23
research article (23) 23
health aspects (22) 22
stomach cancer (22) 22
chemotherapy (21) 21
gene-expression (21) 21
medicine (21) 21
metastasis (21) 21
pathology (21) 21
risk factors (21) 21
stomach neoplasms - metabolism (21) 21
tumors (21) 21
cell line, tumor (20) 20
cells (20) 20
gene expression regulation, neoplastic (20) 20
genes (20) 20
dna methylation (19) 19
gastroenterology and hepatology (19) 19
genetic aspects (19) 19
usage (19) 19
anxiety (18) 18
apoptosis (18) 18
cost-effectiveness (18) 18
disease (18) 18
identification (18) 18
metaanalysis (18) 18
colliding beams [p p] (17) 17
further section (17) 17
immunology (17) 17
inflammation (17) 17
medicine & public health (17) 17
mental depression (17) 17
mutation (17) 17
nuclear experiment (17) 17
original paper (17) 17
patients (17) 17
physics, particles & fields (17) 17
psychotherapy (17) 17
stomach (17) 17
therapy (17) 17
efficacy (16) 16
mental disorders (16) 16
mental health (16) 16
multidisciplinary sciences (16) 16
scattering [p p] (16) 16
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (8) 8
UTL at Downsview - May be requested (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Gerstein Science - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (702) 702
German (15) 15
French (8) 8
Chinese (2) 2
Hungarian (1) 1
Italian (1) 1
Korean (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy
by Smeets, Dominiek and Miller, Ian S and O’Connor, Darran P and Das, Sudipto and Moran, Bruce and Boeckx, Bram and Gaiser, Timo and Betge, Johannes and Barat, Ana and Klinger, Rut and van Grieken, Nicole C. T and Cremolini, Chiara and Prenen, Hans and Mazzone, Massimiliano and Depreeuw, Jeroen and Bacon, Orna and Fender, Bozena and Brady, Joseph and Hennessy, Bryan T and McNamara, Deborah A and Kay, Elaine and Verheul, Henk M and Maarten, Neerincx and Gallagher, William M and Murphy, Verena and Prehn, Jochen H. M and Koopman, Miriam and Punt, Cornelis J. A and Loupakis, Fotios and Ebert, Matthias P. A and Ylstra, Bauke and Lambrechts, Diether and Byrne, Annette T
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 4112 - 16
Increased copy number alterations (CNAs) indicative of chromosomal instability (CIN) have been associated with poor cancer outcome. Here, we study CNAs as... 
COLON-CANCER | READ ALIGNMENT | RANDOMIZED PHASE-III | MICROSATELLITE INSTABILITY | MULTIDISCIPLINARY SCIENCES | CONSENSUS MOLECULAR SUBTYPES | 1ST-LINE THERAPY | PLUS BEVACIZUMAB | BURROWS-WHEELER TRANSFORM | ENDOTHELIAL GROWTH-FACTOR | CHROMOSOMAL INSTABILITY | Bevacizumab - therapeutic use | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Adenocarcinoma - drug therapy | DNA Copy Number Variations | Xenograft Model Antitumor Assays | Animals | Antineoplastic Agents, Immunological - therapeutic use | Colorectal Neoplasms - drug therapy | Female | Adenocarcinoma - genetics | Aged | Mice | Retrospective Studies | Chromosomal Instability | Microsatellites | Stability | Copy number | Xenotransplantation | Colorectal carcinoma | Colorectal cancer | Metastasis | Bevacizumab | Metastases | Genomic instability | Chemotherapy | Xenografts | Clusters | Biomarkers | Bioindicators | Cancer | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer
by Zhan, Tianzuo and Ambrosi, Giulia and Wandmacher, Anna Maxi and Rauscher, Benedikt and Betge, Johannes and Rindtorff, Niklas and Häussler, Ragna S and Hinsenkamp, Isabel and Bamberg, Leonhard and Hessling, Bernd and Müller-Decker, Karin and Erdmann, Gerrit and Burgermeister, Elke and Ebert, Matthias P and Boutros, Michael
Nature Communications, ISSN 2041-1723, 12/2019, Volume 10, Issue 1, pp. 2197 - 17
In colorectal cancer (CRC), aberrant Wnt signalling is essential for tumorigenesis and maintenance of cancer stem cells. However, how other oncogenic pathways... 
COLON-CANCER | LUNG | AXIN | APC | MULTIDISCIPLINARY SCIENCES | RESISTANCE | DIFFERENTIATION | BETA-CATENIN | ENDOCYTOSIS | PROMOTES | ERK | Wnt protein | Colorectal carcinoma | Colorectal cancer | Homeostasis | Stem cell transplantation | Synergism | β-catenin | Signal transduction | Organoids | Intestine | Plasticity | Tumorigenesis | Inhibition | CRISPR | MEK inhibitors | Embryos | Screens | Adenomatous polyposis coli | Signaling | Inhibitors | Cell lines | Stem cells | Plastic properties | Mutation | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)
by Meindl-Beinker, Nadja M and Betge, Johannes and Gutting, Tobias and Burgermeister, Elke and Belle, Sebastian and Zhan, Tianzuo and Schulte, Nadine and Maenz, Martin and Ebert, Matthias P and Haertel, Nicolai
BMC Cancer, ISSN 1471-2407, 03/2019, Volume 19, Issue 1, pp. 231 - 231
BackgroundAdvanced esophageal squamous cell cancer (ESCC) is frequently diagnosed in elderly patients. The impact of 2nd line chemotherapy is poorly defined.... 
Checkpoint inhibitors | Comprehensive geriatric assessment | Esophageal squamous cell cancer | Personalized medicine | Elderly | Geriatric oncology | MANAGEMENT | DOCETAXEL | CHECKPOINT BLOCKADE | LUNG-CANCER | PEMBROLIZUMAB | ALCOHOL | ONCOLOGY | RECURRENT | CLINICAL ACTIVITY | CARCINOMA | PLUS IPILIMUMAB | Evaluation | Care and treatment | Squamous cell carcinoma | Ipilimumab | Oncology, Experimental | Clinical trials | Aged patients | Labels | Research | Chemotherapy | Carboplatin | Product development | Comparative analysis | Esophageal cancer | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Management of immune related adverse events induced by immune checkpoint inhibition
by Teufel, Andreas and Zhan, Tianzuo and Härtel, Nicolai and Bornschein, Jan and Ebert, Matthias P and Schulte, Nadine
Cancer Letters, ISSN 0304-3835, 08/2019, Volume 456, pp. 80 - 87
In recent years, immune checkpoint inhibitors (ICIs) were successfully introduced to cancer therapy and these drugs have already become essential for the... 
Pembrolizumab | Nivolumab | Ipilimumab | PD-L1 | Immune related adverse events | CTLA-4 | irAE | Checkpoint blockade | PD-1 | STAGE-III MELANOMA | SOLID TUMORS | PD-1 PATHWAY | CANCER-IMMUNOTHERAPY | CLINICAL-FEATURES | METASTATIC MELANOMA | ONCOLOGY | EVOLVING ROLE | DOUBLE-BLIND | NIVOLUMAB-INDUCED COLITIS | MISMATCH REPAIR DEFICIENCY | Thyroid gland | Metastasis | Kinases | Cancer therapies | Immunosuppressive agents | Drug dosages | Protein-tyrosine kinase | Immune system | Tyrosine | Activities of daily living | Mortality | Hospitalization | FDA approval | Hypothyroidism | Inflammatory bowel disease | Side effects | Immunosuppression | Chemotherapy | Inhibitors | Immune checkpoint | Antibiotics | Biopsy | Biomarkers | Autoimmune diseases | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo
by Yu, Jun and Qiao, Liang and Zimmermann, Lars and Ebert, Matthias P. A and Zhang, Hongxia and Lin, Wendy and Röcken, Christoph and Malfertheiner, Peter and Farrell, Geoffrey C
Hepatology, ISSN 0270-9139, 01/2006, Volume 43, Issue 1, pp. 134 - 143
Peroxisome proliferator‐activated receptor γ (PPARγ) has been implicated in the differentiation and growth inhibition of cancer cells. We examined the effects... 
LUNG-CANCER | LIGANDS SUPPRESS | ACTIVATED-RECEPTOR-GAMMA | GENE-EXPRESSION | PPAR-GAMMA | CYCLOOXYGENASE-2 EXPRESSION | COLON CARCINOGENESIS | CELL-CYCLE ARREST | SENESCENCE | HUMAN BREAST-CANCER | GASTROENTEROLOGY & HEPATOLOGY | PPAR gamma - drug effects | Humans | Middle Aged | RNA, Messenger - analysis | Male | Thiazolidinediones - therapeutic use | Chromans - pharmacology | Cyclooxygenase 2 - genetics | Female | Liver Neoplasms - pathology | Antineoplastic Agents - pharmacology | Tumor Cells, Cultured | Thiazolidinediones - pharmacology | PPAR gamma - genetics | Cyclin-Dependent Kinase Inhibitor p21 - biosynthesis | Cell Survival | Liver Neoplasms - drug therapy | Cyclooxygenase 2 - analysis | PPAR gamma - physiology | Animals | Chromans - therapeutic use | Cyclin-Dependent Kinase Inhibitor p27 - biosynthesis | Liver Neoplasms, Experimental - drug therapy | Mice | Mice, Inbred BALB C | Cell Cycle - drug effects | Apoptosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Correction to: Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours
by Nwosu, Zeribe C and Battello, Nadia and Rothley, Melanie and Piorońska, Weronika and Sitek, Barbara and Ebert, Matthias P and Hofmann, Ute and Sleeman, Jonathan and Wölfl, Stefan and Meyer, Christoph and Megger, Dominik A and Dooley, Steven
Journal of experimental & clinical cancer research : CR, ISSN 1756-9966, 11/2018, Volume 37, Issue 1, pp. 267 - 267
In the publication of this article (1), there is an error in Fig. 5b. This has now been updated in the original article (1). 
Liver cancer | Gene expression | Metabolism | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Detection of mutational patterns in cell‐free DNA of colorectal cancer by custom amplicon sequencing
by Herrmann, Simon and Zhan, Tianzuo and Betge, Johannes and Rauscher, Benedikt and Belle, Sebastian and Gutting, Tobias and Schulte, Nadine and Jesenofsky, Ralf and Härtel, Nicolai and Gaiser, Timo and Hofheinz, Ralf‐Dieter and Ebert, Matthias P and Boutros, Michael
Molecular Oncology, ISSN 1574-7891, 08/2019, Volume 13, Issue 8, pp. 1669 - 1683
Monitoring the mutational patterns of solid tumors during cancer therapy is a major challenge in oncology. Analysis of mutations in cell‐free (cf) DNA offers a... 
colorectal cancer | DNA | liquid biopsy | next‐generation sequencing | STORAGE | READ ALIGNMENT | next-generation sequencing | BIOPSY | ACQUIRED-RESISTANCE | HETEROGENEITY | BIOMARKERS | PLASMA | EVOLUTION | CIRCULATING TUMOR DNA | ONCOLOGY | cfDNA | Plasma | Epidermal growth factor receptors | Cloning | Colorectal carcinoma | Colorectal cancer | Metastasis | Drug resistance | Cancer therapies | Epidermal growth factor | Gene frequency | Biopsy | Primers | Medical prognosis | Conflicts of interest | Mutation | Solid tumors | Bioinformatics | Growth factors | Deoxyribonucleic acid--DNA | Methods | DNA sequencing | Cancer | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis
by Weichert, Wilko, Dr and Röske, Annika and Gekeler, Volker, PhD and Beckers, Thomas, PhD and Ebert, Matthias PA, Prof and Pross, Matthias, MD and Dietel, Manfred, Prof and Denkert, Carsten, MD and Röcken, Christoph, Prof
Lancet Oncology, The, ISSN 1470-2045, 2008, Volume 9, Issue 2, pp. 139 - 148
Summary Background Although histone deacetylases (HDACs) are known to have an important regulatory role in cancer cells, and HDAC inhibitors (HDIs) have... 
Hematology, Oncology and Palliative Medicine | APOPTOSIS | CARCINOGENESIS | GASTROINTESTINAL ADENOCARCINOMA CELLS | ONCOLOGY | INHIBITORS FK228 | GENE-EXPRESSION | PROLIFERATION | DIFFERENTIATION | TISSUES | ACID BIS-HYDROXAMIDE | VORINOSTAT | Immunohistochemistry | Histone Deacetylases - analysis | Histone Deacetylases - biosynthesis | Prognosis | Biomarkers, Tumor - analysis | Humans | Middle Aged | Stomach Neoplasms - metabolism | Lymphatic Metastasis | Biomarkers, Tumor - classification | Histone Deacetylases - classification | Protein Isoforms | Survival Analysis | Protein Array Analysis | Aged | Retrospective Studies | Biomarkers, Tumor - biosynthesis | Cancer patients | Stomach cancer | Analysis | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text The authors reply
by Ebert, Matthias P. A and Tänzer, Marc
New England Journal of Medicine, ISSN 0028-4793, 03/2012, Volume 366, Issue 10, p. 966
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions
by Tänzer, Marc and Balluff, Benjamin and Distler, Jürgen and Hale, Kari and Leodolter, Andreas and Röcken, Christoph and Molnar, Bela and Schmid, Roland and Lofton-Day, Catherine and Schuster, Tibor and Ebert, Matthias P. A
PLoS ONE, ISSN 1932-6203, 02/2010, Volume 5, Issue 2, pp. e9061 - e9061
Background: Screening for colorectal cancer (CRC) has shown to reduce cancer-related mortality, however, acceptance and compliance to current programmes are... 
ASSAY | COLITIS | FECAL OCCULT BLOOD | ADENOCARCINOMA | MULTIDISCIPLINARY SCIENCES | CANCER | DNA-METHYLATION | Cytoskeletal Proteins - genetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | GTP-Binding Proteins - genetics | Colorectal Neoplasms - diagnosis | Young Adult | DNA Methylation | Precancerous Conditions - diagnosis | Sensitivity and Specificity | Polymerase Chain Reaction | Aged, 80 and over | Adult | Female | DNA, Neoplasm - analysis | Colorectal Neoplasms - blood | Septins | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Precancerous Conditions - genetics | Aged | Biomarkers, Tumor - genetics | DNA, Neoplasm - genetics | Precancerous Conditions - blood | Cohort Studies | Prevention | Epigenetic inheritance | Colonoscopy | Oncology, Experimental | Mortality | Colorectal cancer | Research | Diagnosis | Methylation | Health aspects | Cancer | Plasma | Genes | Colorectal carcinoma | Blood tests | Metastasis | Stomach cancer | DNA methylation | Bioindicators | Colon | Feces | Lesions | Deoxyribonucleic acid--DNA | Predictive control | Invasiveness | Patients | Esophagus | Inflammatory bowel disease | Medicine | Screening | Epigenetics | Biomarkers | Genetic testing | Polyps | Tumors | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C
by Weidner, Philip and Boettche, Dominik and Zimmerer, Thomas and Burgermeister, Elke and Teufel, Andreas and Ebert, Matthias P. A and Antoni, Christoph
Journal of Gastrointestinal and Liver Diseases, ISSN 1841-8724, 09/2018, Volume 27, Issue 3, pp. 281 - 289
Background & Aim: With the development of direct acting antiviral agents (DAA) chronic hepatitis C virus (HCV) infection has become curable in most patients.... 
Diabetes | Hepatitis C | Metabolism | Direct acting antiviral | direct acting antiviral | VIRUS-INFECTION | FATTY LIVER-DISEASE | GENOTYPE 1 | DIABETES-MELLITUS | SIMPLE NONINVASIVE INDEX | INSULIN-RESISTANCE | SIGNIFICANT FIBROSIS | PEGYLATED INTERFERON | VIROLOGICAL CURE | metabolism | GASTROENTEROLOGY & HEPATOLOGY | diabetes | DACLATASVIR PLUS SOFOSBUVIR
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Pharmacological treatment of hepatocellular carcinoma with cavoatrial tumor thrombus - case series and literature review
by Zhan, Tianzuo and Sollors, Janina and Steinebrunner, Niels and Schlitt, Hans Jürgen and Stroszczynski, Christian and Weiss, Karl Heinz and Ebert, Matthias P and Teufel, Andreas
Zeitschrift fur Gastroenterologie, 04/2019, Volume 57, Issue 4, p. 501
Hepatocellular carcinomas (HCC) that extend into the vena cava and the right atrium have a poor prognosis. Surgical approaches including partial hepatectomy... 
Journal Article
Details down arrow
13. Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C
by Weidner, Philip and Boettche, Dominik and Zimmerer, Thomas and Burgermeister, Elke and Teufel, Andreas and Ebert, Matthias P A and Antoni, Christoph
Journal of gastrointestinal and liver diseases : JGLD, 09/2018, Volume 27, Issue 3, p. 281
With the development of direct acting antiviral agents (DAA) chronic hepatitis C virus (HCV) infection has become curable in most patients. Since HCV infection... 
Journal Article
Details down arrow
14. Full Text Caveolin-1 Protects B6129 Mice against Helicobacter pylori Gastritis
: e1003251
by Ivana Hitkova and Gang Yuan and Florian Anderl and Markus Gerhard and Thomas Kirchner and Simone Reu and Christoph Röcken and Claus Schäfer and Roland M Schmid and Roger Vogelmann and Matthias P A Ebert and Elke Burgermeister
PLoS Pathogens, ISSN 1553-7366, 04/2013, Volume 9, Issue 4
  Caveolin-1 (Cav1) is a scaffold protein and pathogen receptor in the mucosa of the gastrointestinal tract. Chronic infection of gastric epithelial cells by... 
Proteins | Ulcers | Rodents | Infections | Gene expression
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text TFAP2E–DKK4 and Chemoresistance in Colorectal Cancer
by Ebert, Matthias P.A and Tänzer, Marc and Balluff, Benjamin and Burgermeister, Elke and Kretzschmar, Antje Karen and Hughes, David J and Tetzner, Reimo and Lofton-Day, Catherine and Rosenberg, Robert and Reinacher-Schick, Anke C and Schulmann, Karsten and Tannapfel, Andrea and Hofheinz, Ralf and Röcken, Christoph and Keller, Gisela and Langer, Rupert and Specht, Katja and Porschen, Rainer and Stöhlmacher-Williams, Jan and Schuster, Tibor and Ströbel, Philipp and Schmid, Roland M
The New England Journal of Medicine, ISSN 0028-4793, 01/2012, Volume 366, Issue 1, pp. 44 - 53
Patients whose tumors showed methylation and decreased expression of the gene TFAP2E were more than five times as likely as patients with normal TFAP2E gene... 
BREAST-CANCER | 5-FLUOROURACIL | MEDICINE, GENERAL & INTERNAL | METHYLATION | INSTABILITY | THYMIDYLATE SYNTHASE | PHASE-III | GENE-EXPRESSION | MUTATIONS | IDENTIFICATION | CARCINOMA | Gene Expression | Microsatellite Instability | Colorectal Neoplasms - genetics | Epigenesis, Genetic | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Intercellular Signaling Peptides and Proteins - genetics | Male | Antineoplastic Agents - therapeutic use | Chemoradiotherapy | Transcription Factor AP-2 - metabolism | Colorectal Neoplasms - therapy | DNA Methylation | Drug Resistance, Neoplasm - genetics | Transcription Factor AP-2 - genetics | DNA - analysis | Colorectal Neoplasms - drug therapy | Cell Line, Tumor | Female | Aged | Mutation | Chemotherapy | Usage | Patient outcomes | Colorectal cancer | Research | Drug therapy | Drug resistance | Cancer | Transcription factors | Peptides | Pathogenesis | Cloning | Colorectal carcinoma | Chemoresistance | Biology | Metastasis | Microsatellite instability | Tumor cell lines | Gene expression | Patients | Metastases | Irinotecan | Oxaliplatin | Plasmids | Cell lines | DNA methylation | Genetic testing | Methylation | Deoxyribonucleic acid--DNA | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Invitation letters increase participation in colorectal cancer screening - results from an observational study
by Zhan, Tianzuo and Hielscher, Thomas and Bilge, Asmé and Giese, Thomas and Schäfer, Christoph and Riemann, Jürgen F and Ebert, Matthias P and Belle, Sebastian
Zeitschrift fur Gastroenterologie, 12/2017, Volume 55, Issue 12, p. 1307
Participation rates in the German colorectal cancer screening program are low. Starting in 2013, a large health insurance plan in Bavaria, Germany, is sending... 
Mass Screening | Early Detection of Cancer | Colonoscopy | Humans | Middle Aged | Patient Participation | Colorectal Neoplasms - prevention & control | Female | Male | Occult Blood | Germany
Journal Article
Details down arrow